Sangrix Inc. balance sheet

At the end of fiscal 2025, Sangrix Inc. had total assets of $3.5m, total liabilities of $372,083 and shareholders' equity of $3.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sangrix Inc.: balance sheet, annual
Fiscal year	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025
Cash and equivalents	0	0	3	1	0	0	0	1	0
Receivables	—	24	40	10	11	0	0	0	—
Inventory	—	0	0	0	0	—	—	—	—
Total current assets	—	29	46	50	33	24	4	7	4
Goodwill	—	—	0	5	0	—	—	—	—
Total assets	—	34	51	63	41	35	13	7	4
Accounts payable	—	3	9	6	10	—	1	—	—
Deferred revenue (current)	—	1	1	1	4	—	—	—	—
Total current liabilities	—	17	23	33	39	0	3	2	0
Short-term debt	—	5	0	1	10	—	—	—	—
Total debt	0	5	6	8	10	—	2	—	—
Total liabilities	—	18	27	37	42	0	3	6	0
Shareholders' equity	10	14	25	24	−3	35	10	2	4
Non-controlling interests and other (assets − liabilities − equity)	—	2	—	3	2	—	—	−1	−1
Net debt (negative = net cash)	−0	5	4	7	10	−0	2	−1	−0
Shares outstanding	—	—	—	—	—	18m	—	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: SGRX vs SNTG MI vs SGRX DCM vs SGRX

More: Diversified Financial Services stocks compared, Financials sector, rankings of US companies

Figures from Sangrix Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sangrix Inc.